Adicet Bio Inc. (ACET)

AI Score

Unlock

0.63

-0.04 (-6.11%)

At close: Apr 04, 2025, 3:59 PM

0.65

3.36%

After-hours: Apr 04, 2025, 05:59 PM EDT

Adicet Bio Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009	Jun 30, 2008
Revenue	n/a	n/a	24.99M	9.73M	17.9M	995K	8.18M	558.52M	546.95M	510.18M	499.69M	499.69M	444.39M	412.43M	346.63M	322.65M	359.59M
Cost of Revenue	n/a	6.1M	5.01M	n/a	n/a	125K	80K	5K	411.52M	395.48M	401.42M	401.42M	362.36M	346.59M	292.48M	267.03M	292.29M
Gross Profit	n/a	-6.1M	19.98M	9.73M	17.9M	870K	8.1M	558.52M	135.43M	114.7M	98.27M	98.27M	82.03M	65.84M	54.16M	55.62M	67.31M
Operating Income	-127.61M	-152.04M	-72.55M	-61.43M	-39.19M	-31.39M	-14.96M	-18.88M	-1K	44.27M	34.42M	34.42M	25.37M	16.55M	9.44M	11.89M	21.38M
Interest Income	10.71M	9.95M	3.76M	91K	785K	938K	543K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-117.12M	-142.66M	-69.79M	-62.12M	-39.49M	-28.12M	-9.89M	-33.78M	-1K	44.67M	34.55M	34.55M	24.74M	16.96M	10.2M	12.73M	22.19M
Net Income	-117.12M	-142.66M	-67.03M	-62M	-36.68M	-28.14M	-9.3M	-33.78M	-1K	29M	22.33M	22.33M	16.98M	8.97M	6.58M	8.63M	13.47M
Selling & General & Admin	28.29M	26.53M	26.3M	22.22M	22.76M	8.69M	8.43M	2.04M	1K	65.21M	61.02M	63.85M	56.67M	49.29M	44.72M	43.57M	45.42M
Research & Development	99.32M	106.04M	71.25M	48.94M	34.33M	23.69M	14.72M	16.84M	5.94M	5.22M	2.83M	n/a	n/a	n/a	n/a	153K	506K
Other Expenses	n/a	19.46M	-919K	-606K	-953K	2.33M	4.53M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	127.61M	152.04M	97.54M	71.16M	57.09M	32.38M	23.14M	18.88M	1K	70.43M	63.85M	63.85M	56.67M	49.29M	44.72M	43.73M	45.93M
Interest Expense	-4K	n/a	80K	176K	134K	n/a	n/a	7M	3.95M	2.1M	2.12M	2.12M	2.63M	1.57M	230K	98K	145K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-74.78M	-73.16M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	152.04M	97.54M	71.16M	57.09M	32.38M	23.14M	18.88M	1K	465.91M	465.27M	465.27M	419.02M	395.88M	337.19M	310.75M	338.21M
Income Tax Expense	n/a	n/a	-2.76M	-125K	-2.81M	19K	-589K	19.09M	20.38M	15.67M	12.22M	12.22M	7.76M	7.99M	3.62M	4.1M	8.72M
Shares Outstanding (Basic)	87.87M	43.04M	41.08M	30.95M	7.32M	18.56M	29.8M	26.77M	28.05M	24.5M	23.67M	23.67M	23.26M	22.67M	21.86M	21.43M	21.3M
Shares Outstanding (Diluted)	87.87M	43.04M	41.08M	30.95M	7.32M	18.56M	29.8M	26.97M	28.05M	24.99M	24.02M	24.02M	23.46M	22.84M	22.07M	21.86M	21.7M
EPS (Basic)	-1.33	-3.31	-1.63	-2	-5.01	-1.52	-0.31	-1.26	n/a	1.18	0.94	0.94	0.73	0.40	0.30	0.40	0.63
EPS (Diluted)	-1.33	-3.31	-1.63	-2	-5.01	-1.52	-0.31	-1.25	n/a	1.16	0.93	0.93	0.72	0.39	0.30	0.39	0.62
EBITDA	-127.61M	-136.53M	-64.7M	-60.41M	-37.41M	-26.88M	-13.74M	-33.77M	-1K	54.87M	43.62M	43.62M	34.31M	24.03M	13.23M	14.7M	24.71M
EBIT	-117.13M	-142.63M	-69.71M	-61.95M	-39.36M	-28.12M	-14.96M	-33.78M	-1K	46.77M	36.67M	36.67M	27.37M	18.53M	10.43M	12.83M	22.33M
Depreciation & Amortization	n/a	6.1M	5.01M	4.07M	1.95M	1.24M	80K	5K	11.85M	8.09M	6.94M	6.94M	6.94M	5.5M	2.8M	1.87M	2.38M